NYU Conference on Ibogaine Nov 5-6, 1999

SUPPRESSANT EFFECTS OF IBOGAINE AND ITS PRIMARY METABOLITE ON ALCOHOL INTAKE IN THREE STRAINS OF ALCOHOL PREFERRING RATS.
Amir H., Rezvani, D.C. Mash, W.L. Hearn, D.H. Overstreet, Y.W. Lee. Abstract
Center for Alcohol Studies and Department of Psychiatry, UNC School of Medicine Chapel Hill, Chapel Hill, NC 27599-7178

MECHANISMS OF ANTI-ADDICTIVE ACTIONS OF IBOGAINE.
Stanley D. Glick, Isabelle M. Maisonneuve and Sandra M. Pearl. Abstract,   Full text PDF format
Department of Pharmacology and Neuroscience, Albany Medical College, Albany, NY 12208, USA.

IBOGAINE, TRAUMA AND ABREACTION IN THE TREATMENT OF CHEMICAL DEPENDENCE.
H.S. Lotsof¹, C.A. Smith F.² and J. Bastiaans³. Abstract,   Full text
¹NDA Intermational, Inc., 46 Oxford Place, Staten Island, NY 10301; ²Chairman, Republic of Panama Chapter, American Society of Addiction Medicine (ASAM); ³Oegstgeest, The Netherlands (deceased).

NEUROLOGIC AND EEG OBSERVATIONS IN SUBJECTS ADMINISTERED IBOGAINE.
Daniel Luciano¹, Ezequiel Jethmal G.², and Edgardo A. Della Sera³. Abstract   Full text
Laboratory of Neuroscience, NIDDK, NIH, Bethesda, MD 20892, USA. ^*Institute
¹Hospital for Joint Diseases/NYU School of Medicine; ²Centro Medico Paitilla, Panama City, Republic of Panama; ³Founding Member, Republic of Panama Chapter, American Society of Addiction Medicine (ASAM).

STRUCTURALLY MODIFIED ANALOGUES OF IBOGAINE EXHIBIT DIFFERING AFFINITIES FOR NMDA RECEPTORS: IMPLICATIONS FOR ITS PUTATIVE ANTI-ADDICTIVE PROPERTIES.
Richard T. Layer, Phil Skolnick, Craig M. Bertha, Martin E. Kuehne and Piotr Popik^*. Abstract of Pharmacology Polish Academy of Science, Smetna 12, 31-343, Krakow, Poland